Leadership Overview
Orchid Pharma has 4 executives leading key functions including strategy, information technology, global procurement, and corporate operations.
Focused on delivering high-quality healthcare solutions, Orchid Pharma maintains a commitment to innovation and corporate social responsibility while building a sustainable ecosystem for global pharmaceutical growth.
Focused on delivering high-quality healthcare solutions, Orchid Pharma maintains a commitment to innovation and corporate social responsibility while building a sustainable ecosystem for global pharmaceutical growth.
Leadership Roles at Orchid Pharma
Kavitha Priya - Chief Executive Officer
Kavitha Priya, the Chief Executive Officer at Orchid Pharma, directs the overarching strategic vision and long-term growth trajectory of the organization. By overseeing the integration of research, manufacturing, and marketing capabilities, the Chief Executive Officer ensures alignment across all therapeutic domains. Kavitha Priya manages high-level interactions with the Board to drive sustainable value for healthcare providers and global partners. This leadership role involves identifying new market opportunities and fostering an internal culture centered on innovation. Through rigorous oversight of operational performance, the Chief Executive Officer maintains the competitive edge of the company within the pharmaceutical sector. By prioritizing corporate social responsibility, the executive secures the reputation of the firm as a leader in healthcare solutions. Ultimately, the Chief Executive Officer optimizes the organizational structure to support the discovery of new growth avenues while maintaining excellence in pharmaceutical manufacturing and delivery.
Mani Sivaswamy - President
Mani Sivaswamy, the President at Orchid Pharma, oversees the daily operational execution and cross-functional alignment of the company's diverse business units. By managing the synergy between research, manufacturing, and marketing, the President ensures that the organization meets its strategic objectives in the healthcare sector. Mani Sivaswamy drives the implementation of operational policies that foster a culture of innovation and professional growth. This leadership role involves coordinating with other C-suite executives to refine the corporate strategy and improve market impact. Through the supervision of regional operations, the President maintains high standards of quality control and regulatory compliance. By optimizing internal workflows, the executive enhances the overall productivity of the workforce. Ultimately, the President provides the necessary guidance to ensure that the company remains a reliable partner for healthcare providers, consistently delivering high-quality pharmaceutical products while maintaining a focus on sustainable organizational development and long-term market success.
Pragati Patro - Head of IT (Chief Information Officer)
Pragati Patro, the Head of IT (Chief Information Officer) at Orchid Pharma, architects the digital infrastructure necessary to support complex pharmaceutical research and manufacturing processes. Overseeing the implementation of advanced data analytics and secure information systems, the Head of IT (Chief Information Officer) ensures that all technological assets remain compliant with global healthcare standards. Pragati Patro drives the digital transformation strategy, enabling seamless communication between research laboratories and production facilities. This leadership role involves managing cybersecurity protocols to protect sensitive intellectual property and patient data. By optimizing internal software ecosystems, the Head of IT (Chief Information Officer) increases operational efficiency across the entire supply chain. Through the deployment of scalable cloud solutions, the executive supports the rapid expansion of market reach. Ultimately, the Head of IT (Chief Information Officer) provides the technological foundation required for the company to deliver comprehensive pharmaceutical solutions to healthcare organizations worldwide.
Navdeep Aggarwal - Global Vice President, Head (Projects & Managing Director, Procurement) Reporting To
Navdeep Aggarwal, the Global Vice President, Head (Projects & Managing Director, Procurement) Reporting To at Orchid Pharma, manages the complex procurement networks and large-scale project execution required for pharmaceutical manufacturing. Overseeing the acquisition of raw materials and the coordination of global supply chains, the Global Vice President, Head (Projects & Managing Director, Procurement) Reporting To ensures that production timelines meet market demand. Navdeep Aggarwal directs the strategic sourcing initiatives that maintain cost-efficiency without compromising quality standards. This leadership role involves negotiating with international suppliers and managing the logistics of global distribution. By streamlining procurement processes, the Global Vice President, Head (Projects & Managing Director, Procurement) Reporting To minimizes operational risks and enhances the reliability of the manufacturing ecosystem. Through the management of capital projects, the executive supports the infrastructure development necessary for long-term growth. Ultimately, the Global Vice President, Head (Projects & Managing Director, Procurement) Reporting To secures the supply chain integrity essential for delivering pharmaceutical solutions.
Explore Leadership Teams in Manufacturing
Founded in 1949 and Headquartered in Mumbai, India, Ipca Laboratories Limited (IPCA) is a fully integrated pharmaceutical company manufacturing and marketing over 350 formulations and 80 API's covering various therapeutic segments.
Company Leadership AP
SM
SN
Synokem Pharmaceuticals Ltd is a rising pharmaceutical organization established in 1983, specializing in contract manufacturing, ethical marketing, exports, and institutional supplies. The company aims to provide quality pharmaceutical products that are affordable to all sections of society, with a vision to become a world-class manufacturer. Synokem is committed to enhancing its market share through strategic alliances and collaborations, particularly in the international business sector. With a focus on research and development, the company is dedicated to achieving significant growth and establishing itself as an industry leader.
Company Leadership PS
SA
AK
RM
Cohance is a global Contract Development and Manufacturing Organization (CDMO) specializing in Antibody Drug Conjugates (ADCs), Nucleic Acid Chemistry, and Small Molecules. The company offers a wide range of services including API development, manufacturing, and clinical analytical services, aimed at accelerating the pipeline for pharmaceutical innovators. With a commitment to sustainability and quality, Cohance partners with clients to provide integrated solutions from discovery to commercial scale. Their expertise and innovative approach make them a trusted partner for complex molecule development and manufacturing needs.
Company Leadership
YD
SS
RS
Bliss GVS Pharma Limited is a global pharmaceutical company specializing in the manufacturing of a wide range of pharmaceutical products, including capsules, creams, injections, and various healthcare items. The company is recognized as the world's largest manufacturer of suppositories and pessaries, operating world-class facilities that prioritize quality and efficiency. Their mission focuses on discovering and rediscovering pharmaceutics to enhance well-being while increasing the accessibility of pharmaceuticals worldwide. The intended clients include healthcare providers and consumers seeking reliable and effective pharmaceutical solutions.
Company Leadership VD
SJ
AM
DS